Marc Forth

President & Chief Executive Officer
Jeune Aesthetics

Biography

Mr. Forth joined Jeune Aesthetics as President & CEO in April 2025. However, Mr. Forth’s has served as a valuable contributor on Jeune’s Board of Directors since February 2021. Mr. Forth has nearly 30 years of healthcare experience with a deep background in medical aesthetics, medical dermatology, neurosciences, urology and gynecology. He joins the company at a critical and exciting time, leading the transformation of Jeune into a independent, late-stage company focused on the development of truly innovative treatments designed to address the biology of aging skin.

Prior to Jeune Aesthetics, Mr. Forth spent nearly 6 years as the President & CEO of AEON Biopharma, Inc., a clinical stage, public company focused on the development of botulinum toxin designed to treat an array of nervous system-related conditions. Mr. Forth led the exclusive licensure for therapeutic use of ABP-450 in the U.S., Canada, Europe, Australia and other geographies from Daewoong Pharmaceutical Co., Ltd. and designed the corporate, development and regulatory strategies for ABP-450 in cervical dystonia, migraine and gastroparesis. Mr. Forth continues to serve on AEON Biopharma’s Board of Directors.

A veteran of the healthcare industry, Mr. Forth previously worked at Allergan PLC as the Senior Vice-President and Division Head for the U.S. Neurosciences, Urology and Medical Dermatology Divisions. During his 16-year tenure at Allergan, Mr. Forth was responsible for all aspects of the commercialization of neurosciences, urology and medical dermatology products, most notably Botox® for all therapeutic uses and, earlier in his career, led the commercial planning and execution for BOTOX® Cosmetic in the United States.

Mr. Forth started his career in healthcare at TAP Pharmaceuticals, holding numerous commercial roles for more than 7 years. Beginning as a Sales Representative, Mr. Forth gained experience in sales management, marketing, and payer marketing in urology, oncology, gynecology, and gastroenterology. Prior to TAP Pharmaceuticals, Mr. Forth worked at WSW Associates for 4 years, where he initially began his career as an Account Executive specializing in marketing, advertising, and public relations.

Mr. Forth received a B.S. in Business Administration from California State University, Fresno and a Graduate Marketing Certification from Southern Methodist University.